Citation: R. Mouele et al., Haemoglobin F (HbF) levels in sickle-cell anaemia patients homozygous for the Bantu haplotype, EUR J HAEMA, 63(2), 1999, pp. 136-137
Authors:
Eisinger, F
Alby, N
Bremond, A
Dauplat, J
Espie, M
Janiaud, P
Kuttenn, F
Lebrun, JP
Lefranc, JP
Pierret, J
Sobol, H
Stoppa-Lyonnet, D
Thouvenin, D
Tristant, H
Feingold, J
Citation: F. Eisinger et al., Recommendations for medical management of hereditary breast and ovarian cancer: the Inserm-FNCLCC ad hoc committee, B CANCER, 86(3), 1999, pp. 307-313
Authors:
Leboyer, M
Philippe, A
Bouvard, M
Guilloud-Bataille, M
Bondoux, D
Tabuteau, F
Feingold, J
Mouren-Simeoni, MC
Launay, JM
Citation: M. Leboyer et al., Whole blood serotonin and plasma beta-endorphin in autistic probands and their first-degree relatives, BIOL PSYCHI, 45(2), 1999, pp. 158-163
Authors:
Bellivier, F
Leboyer, M
Courtet, P
Feingold, J
Buresi, C
Malafosse, A
Citation: F. Bellivier et al., No allelic association between bipolar affective disorder and the tryptophan hydroxylase gene - In reply, ARCH G PSYC, 56(1), 1999, pp. 101-101
Authors:
Fang, LJ
Feingold, J
Lemieux, B
Thirion, JP
Citation: Lj. Fang et al., A novel and very peculiar HincII polymorphism in the 5 ' region of the human neurofibromatosis type 1 (NF1) gene, ANN GENET, 42(4), 1999, pp. 231-233
Citation: J. Yaouanq et al., French Society for Human Genetics. "Genetics in practice" commission. Corescientific data of use in genetic counseling. Hemochromatosis., ANN GENET, 42(4), 1999, pp. 234-240
Citation: J. Feingold et M. Guilloud-bataille, Genetic comparisons of patients with cystic fibrosis with or without meconium ileus, ANN GENET, 42(3), 1999, pp. 147-150
Authors:
Houdayer, C
Soupre, V
Rosenberg-Bourgin, M
Martinez, H
Tredano, M
Feldmann, D
Feingold, J
Aymard, P
Munnich, A
Le Bouc, Y
Vazquez, MP
Bahuau, M
Citation: C. Houdayer et al., Linkage analysis of 5 novel van der Woude syndrome kindreds to 1q32-q41 markers further supports locus homogeneity of the disease trait, ANN GENET, 42(2), 1999, pp. 69-74
Authors:
Eisinger, F
Alby, N
Bremond, A
Dauplat, J
Espie, M
Janiaud, P
Kuttenn, F
Lebrun, JP
Lefranc, JP
Pierret, J
Sobol, H
Stoppa-Lyonnet, D
Thouvenin, D
Tristant, H
Feingold, J
Citation: F. Eisinger et al., Recommendations for medical management of hereditary breast and ovarian cancer: the INSERM-FNCLCC ad hoc committee, ANN GENET, 42(1), 1999, pp. 51-64
Authors:
Mouele, R
Boukila, V
Fourcade, V
Feingold, J
Galacteros, F
Citation: R. Mouele et al., Sickle-cell disease in Brazzaville, Congo: Genetical, hematological, biochemical and clinical aspects, ACT HAEMAT, 101(4), 1999, pp. 178-184
Authors:
Gargiulo, M
Prouvost, B
Hahn-Barma, V
Lagroua, I
Brice, A
Feingold, J
Durr, A
Citation: M. Gargiulo et al., Scope and temporality in predictive test. Predictive test for the diagnosis of potential Huntington's disease: the experience of a French hospital (La Pitie-Salpetriere, Paris)., PUBLIC HEALTH AND UNIVERSAL ETHICS, 1999, pp. 103-106
Authors:
Eisinger, F
Alby, N
Bremond, A
Dauplat, J
Espie, M
Janiaud, P
Kuttenn, F
Lebrun, JP
Lefranc, JP
Pierret, J
Sobol, H
Stoppa-Lyonnet, D
Thouvenin, D
Tristant, H
Feingold, J
Citation: F. Eisinger et al., Recommendations for medical management of hereditary breast and ovarian cancer: The INSERM-FNCLCC ad hoc committee, ANN ENDOCR, 59(6), 1998, pp. 470-484
Authors:
Jouanolle, AM
Fergelot, P
Raoul, ML
Gandon, G
Roussey, M
Deugnier, Y
Feingold, J
Le Gall, JY
David, V
Citation: Am. Jouanolle et al., Prevalence of the C282Y mutation in Brittany: Penetrance of genetic hemochromatosis?, ANN GENET, 41(4), 1998, pp. 195-198
Citation: F. Eisinger et J. Feingold, Summary of the INSERM-FNCLCC recommendations on the management of women genetically predisposed to breast or ovarian cancer, EUROCANCER 98, 1998, pp. 107-109